Mucosal Protective Compounds in the Treatment of Gastroesophageal Reflux Disease. A Position Paper Based on Evidence of the Romanian Society of Neurogastroenterology. [electronic resource]
- Journal of gastrointestinal and liver diseases : JGLD Dec 2016
- 537-546 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1842-1121
10.15403/jgld.2014.1121.254.dea doi
Alginates--therapeutic use Antacids--adverse effects Consensus Cytoprotection Dimethylpolysiloxanes--therapeutic use Drug Therapy, Combination Esophageal Mucosa--drug effects Gastroesophageal Reflux--diagnosis Humans Patient Selection Protective Agents--adverse effects Proton Pump Inhibitors--therapeutic use Severity of Illness Index Sucralfate--therapeutic use Treatment Outcome